pregabalin capsules cv 100 mg
1 INDICATIONS AND USAGE Pregabalin capsules are indicated for: Neuropathic pain associated with diabetic peripheral neuropathy (DPN) ( 1 ) Postherpetic neuralgia (PHN) ( 1 ) Adjunctive therapy for the treatment of partial-onset seizures in patients 4 years of age and older ( 1 ) Fibromyalgia ( 1 ) Neuropathic pain associated with spinal cord injury ( 1 ) Pregabalin capsules are indicated for: Management of neuropathic pain associated with diabetic peripheral neuropathy Management of postherpetic neuralgia Adjunctive therapy for the treatment of partial-onset seizures in patients 4 years of age and older Management of fibromyalgia Management of neuropathic pain associated with spinal cord injury Pediatric use information is approved for Pfizer's LYRICA (pregabalin) Capsules and Oral Solution products. However, due to Pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information.
cipla usa inc.
CAPSULE ORANGE Cipla 100 mg 681
Cipla 100 mg 681 CAPSULE ORANGE
Related Pills
pregabalin 25 mg
Cipla USA Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 25 mg capsules: white to off white powder filled in size '4' hard gelatin white opaque and white opaque capsule linear printed in black ink with 'Cipla 25 mg' on the cap and '677' on the body; available in: Blister of 10's (NDC 69097-677-19) Carton of 10's x 10's unit-dose capsules (NDC 69097-677-21) Bottle of 30's count with child-resistant cap (NDC 69097-677-02) Bottle of 90's count with child-resistant cap (NDC 69097-677-05) Bottle of 500's count (NDC 69097-677-12) 50 mg capsules: white to off white powder filled in size '3' hard gelatin white opaque and white opaque capsule linear printed in black ink with 'Cipla 50 mg' on the cap and '678' on the body; available in: Blister of 10's (NDC 69097-678-19) Carton of 10's x 10's unit-dose capsules (NDC 69097-678-21) Bottle of 30's count with child-resistant cap (NDC 69097-678-02) Bottle of 90's count with child-resistant cap (NDC 69097-678-05) Bottle of 500's count (NDC 69097-678-12) 75 mg capsules: white to off white powder filled in size '4' hard gelatin orange opaque and white opaque capsule linear printed in black ink with 'Cipla 75 mg' on the cap and '679' on the body; available in: Blister of 10's (NDC 69097-679-19) Carton of 10's x 10's unit-dose capsules (NDC 69097-679-21) Bottle of 30's count with child-resistant cap (NDC 69097-679-02) Bottle of 90's count with child-resistant cap (NDC 69097-679-05) Bottle of 500's count (NDC 69097-679-12) 100 mg capsules: white to off white powder filled in size '3' hard gelatin orange opaque and orange opaque capsule linear printed in black ink with 'Cipla 100 mg' on the cap and '681' on the body; available in: Blister of 10's (NDC 69097-681-19) Carton of 10's x 10's unit-dose capsules (NDC 69097-681-21) Bottle of 30's count with child-resistant cap (NDC 69097-681-02) Bottle of 90's count with child-resistant cap (NDC 69097-681-05) Bottle of 500's count (NDC 69097-681-12) 150 mg capsules: white to off white powder filled in size '2' hard gelatin white opaque and white opaque capsule linear printed in black ink with 'Cipla 150 mg' on the cap and '682' on the body; available in: Blister of 10's (NDC 69097-682-19) Carton of 10's x 10's unit-dose capsules (NDC 69097-682-21) Bottle of 30's count with child-resistant cap (NDC 69097-682-02) Bottle of 90's count with child-resistant cap (NDC 69097-682-05) Bottle of 500's count (NDC 69097-682-12) 200 mg capsules: white to off white powder filled in size '1' hard gelatin light orange opaque and light orange opaque capsule linear printed in black ink with 'Cipla 200 mg' on the cap and '683' on the body; available in: Blister of 10's (NDC 69097-683-19) Carton of 10's x 10's unit-dose capsules (NDC 69097-683-21) Bottle of 30's count with child-resistant cap (NDC 69097-683-02) Bottle of 90's count with child-resistant cap (NDC 69097-683-05) Bottle of 500's count (NDC 69097-683-12) 225 mg capsules: white to off white powder filled in size '1' hard gelatin light orange opaque and white opaque capsule linear printed in black ink with 'Cipla 225 mg' on the cap and '684' on the body; available in: Blister of 10's (NDC 69097-684-19) Carton of 10's x 10's unit-dose capsules (NDC 69097-684-21) Bottle of 30's count with child-resistant cap (NDC 69097-684-02) Bottle of 90's count with child-resistant cap (NDC 69097-684-05) Bottle of 500's count (NDC 69097-684-12) 300 mg capsules: white to off white powder filled in size '0' hard gelatin orange opaque and white opaque capsule linear printed in black ink with 'Cipla 300 mg' on the cap and '685' on the body; available in: Blister of 10's (NDC 69097-685-19) Carton of 10's x 10's unit-dose capsules (NDC 69097-685-21) Bottle of 30's count with child-resistant cap (NDC 69097-685-02) Bottle of 90's count with child-resistant cap (NDC 69097-685-05) Bottle of 500's count (NDC 69097-685-12) Storage and Handling Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) (see USP Controlled Room Temperature).
More pills like CAPSULE Cipla 100 mg 681